Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo

被引：0
作者：
Daniel, C
Hering, K
Lawler, J
Hugo, C
机构：
[1] Univ Erlangen Nurnberg, Med Klin 4, Erlangen, Bavaria, Germany
[2] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2005年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：V236 / V236
页数：1
相关论文
共 50 条
  • [31] REGULATION OF TGF-BETA EXPRESSION IN-VIVO IN EXPERIMENTAL LIVER FIBROSIS
    STROBEL, D
    MULLER, P
    RUOSLAHTI, E
    HAHN, EG
    [J]. HEPATOLOGY, 1995, 22 (04) : 717 - 717
  • [32] Enalapril suppresses glomerular TGF-beta 1 mRNA and progression of diabetic nephropathy in streptozotocin-induced diabetic rats.
    Kim, SI
    Han, DC
    Lee, HB
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2989 - A2989
  • [33] Evaluation of glomerular basement membrane and expression of TGF-beta 1 and fibronectin in renal biopsies of patients with diabetic nephropathy
    dos Reis Monteiro, M. L. Goncalves
    Araujo, L. Silvano
    Silva, C. A.
    de Morais Pereira, L. H.
    Cabo, E. de Castro
    Borges, C. R. Bibiano
    Correa, R. R. Miranda
    Machado, J. R.
    dos Reis, M. Antonia
    [J]. VIRCHOWS ARCHIV, 2016, 469 : S312 - S312
  • [34] Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth
    Lawler, J
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2002, 6 (01) : 1 - 12
  • [35] Effect of lovastatin on glomerular TGF-beta 1 mRNA expression and progression of diabetic nephropathy in streptozotocin-induced diabetic rats.
    Han, DC
    Kim, SI
    Lee, HB
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2969 - A2969
  • [36] Effect of new orally active TGF-beta inhibitor on animal models of diabetic nephropathy.
    Nakagawa, T
    Sugaru, E
    Sakai, M
    Ono-Kishino, M
    Nagamine, J
    Nagata, R
    Taiji, M
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 313A - 313A
  • [37] Thrombospondin-1, An Antiangiogenic and Proapoptic Factor, Is Elevated in The Plasma of Patients with Antiphospholipid Syndrome and is Correlated with Soluble Fas Ligand and Free Active TGF-beta Levels
    Patsouras, Markos D.
    Sikara, Marina P.
    Tzioufas, Athanassios G.
    Vlachoyiannopoulos, Panayiotis G.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S10 - S10
  • [38] THROMBOSPONDIN ACTIVATES LATENT TGF-BETA SECRETED BY ENDOTHELIAL-CELLS
    MURPHYULLRICH, JE
    SCHULTZCHERRY, S
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 128 - 128
  • [39] Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through TGF-beta overactivation
    Hertig, A
    Berrou, J
    Allory, Y
    Breton, L
    Commo, F
    de Beauregard, MAC
    Carmeliet, P
    Rondeau, E
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 174A - 175A
  • [40] Sodium depletion enhances fibrosis and the expression of TGF-beta 1 and matrix proteins in experimental chronic cyclosporine nephropathy
    Shihab, FS
    Andoh, TF
    Tanner, AM
    Bennett, WM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (01) : 71 - 81
12345